www.sciencedaily.com
Two new studies shed light on carcinoma resistance, revealing that tumors can change identity to evade treatment. Researchers have identified key proteins and structures involved in this reprogramming, offering potential targets for future therapies. This deeper understanding of tumor adaptability paves the way for developing highly specific cancer drugs, potentially leading to safer and more effective treatments that target the root causes of resistance. The discoveries represent a significant step towards more selective and less toxic cancer therapies.
